Can a US Citizen with Complex Chronic Illness (CCI) Get Social Security Disability Income (SSDI)

by Dr. Raymond Oenbrink | CIRS, Lyme Disease & Atypical Infections, Neurodegeneration & Brain Health

The Good News? Probably–When the testing is done the right way. How does a chronically ill person go about getting recognition as being disabled? It depends on what is going on with you. One of the most common complaints I see is utter exhaustion, no stamina,...

How to Get Disability for Your Complex Chronic Illness

by Dr. Raymond Oenbrink | CIRS, ElectroMagnetic Field Sensitivity, Functional & Integrative Medicine, ISEAI, Lyme Disease & Atypical Infections, Mast Cell Activation Syndrome, Multiple Chemical Sensitivity (MCS), Neurodegeneration & Brain Health

What is Complex Chronic Illness? Many poor unfortunates suffer from what I like to call “Complex Chronic Illness (CCI)” including such “favorites” as “Chronic Fatigue Syndrome, “Chronic Lyme” “Fibromyalgia” among others. The difficult part of this getting qualified by...

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients

by Dr. Raymond Oenbrink | CIRS, ElectroMagnetic Field Sensitivity, ISEAI

https://molmed.biomedcentral.com/articles/10.1186/s10020-019-0083-4 Comment; Impaired TRPM3 activity in Natural Killer (NK) T lymphocytes can potentially be reversed with Pregnenolone, parent to sex steroids & Nifedepine a calcium channel blocker used to treat...

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

by Dr. Raymond Oenbrink | CIRS, ElectroMagnetic Field Sensitivity, ISEAI

https://www.ncbi.nlm.nih.gov/pubmed/19453963 Comment; Interesting that those with a high RBC sed rate had the best response. Sed rate measures inflammation–but generally not fibromyalgia-type inflammation–yet still predicted the best response to LDN....

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine, ISEAI

https://www.ncbi.nlm.nih.gov/pubmed/23359310 Comment; Small study of 31 patients, crossover design–everybody had intervention-free and intervention intervals studied, improved pain control, fatigue & sleep problems without any significant adverse effects....

Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine, ISEAI

https://www.ncbi.nlm.nih.gov/pubmed/19365548 Comment; This study is using “standard” dosing of Naltrexone, not “low” dose Naltrexone (LDN), yet still provides evidence that the mechanism does not involve classic brain opioid receptors. Younger...

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine, ISEAI

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/ Comment; LDN has been used for years, though incompletely understood regarding how it works. We know it affects Natural Killer T-Lymphocytes, doesn’t seem to work solely by effects on the CNS opioid...

Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine, ISEAI

https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract Comment; Technical Australian paper demonstrating that low-dose naltrexone (LDN) affects Natural Killer T Lymphocyte calcium channels in cell membrane–calcium is an intra-cellular signal...

Altered microbiome composition in individuals with fibromyalgia

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine, ISEAI

https://journals.lww.com/pain/Abstract/publishahead/Altered_microbiome_composition_in_individuals_with.98647.aspx Comment; We’re learning more every day about how our gut microbiome affects our health. From species involved, to factors that affect their...

Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis

by Dr. Raymond Oenbrink | CIRS, Functional & Integrative Medicine

https://fmtest.com/wp-content/uploads/2017/03/Rheumatology.pdf Comment; EpicGenetics is a company that provides basic testing of 4 cytokines–intercellular messengers–associated with inflammation. The claim is that this test estabishes the diagnosis of...

Gut Bacteria Associated with Chronic Widespread Pain for the First Time.

by Dr. Raymond Oenbrink | Addiction, CIRS, Functional & Integrative Medicine, Mast Cell Activation Syndrome, Multiple Chemical Sensitivity (MCS)

https://muhc.ca/newsroom/news/gut-bacteria-associated-chronic-pain-first-time Comment; Something I’ve suspected for a long time, good to see research is panning out in this direction! People with fibromyalgia show variations in microbiome compositionJun 19, 2019...

Critical role of mast cells in inflammatory diseases and the effect of acute stress

by Dr. Raymond Oenbrink | CIRS, ElectroMagnetic Field Sensitivity, Functional & Integrative Medicine, Mast Cell Activation Syndrome, Multiple Chemical Sensitivity (MCS)

https://drive.google.com/file/d/18Anhz5IoDlFvcAploWAZgi7owXA7mdTZ/view?usp=sharing Comment; Good summary article, even though it’s 6 years old, this material is widely unknown in “traditional” medical circles. So many organ systems involved, so many...